Show simple item record

Quality performance of drugs analyzed in the Drug Analysis and Research unit (DARU) during the period 2006-2010.

dc.contributor.authorAbuga, KO
dc.contributor.authorAmugune, BK
dc.contributor.authorNdwigah, SN
dc.contributor.authorKamau, FN
dc.contributor.authorThoithi, GN
dc.contributor.authorOgeto, JO
dc.contributor.authorOkaru, AO
dc.contributor.authorNguyo, JM
dc.contributor.authorKing'Ondu, OK
dc.contributor.authorMugo, HN
dc.contributor.authorKibwage, IO
dc.date.accessioned2015-06-04T13:00:41Z
dc.date.available2015-06-04T13:00:41Z
dc.date.issued2013
dc.identifier.citationEast and Central African Journal of Pharmaceutical Sciences 2013 Vol. 16 No. 2 pp. 33-43en_US
dc.identifier.urihttp://www.cabdirect.org/abstracts/20153010356.html?resultNumber=1&q=au%3A%22Mugo%2C+H.+N.%22
dc.identifier.urihttp://hdl.handle.net/11295/84242
dc.description.abstractDuring the period 2006-2010, the Drug Analysis and Research Unit analyzed 583 samples. The samples comprised 50.6% local and 49.4% imported products. Samples were subjected to compendial or in-house specifications. The failure rate was 12.2% for local products and 14.2% for imports. Antibacterial products recorded the highest failure rate (21.6%) while anticancers and drugs acting on the gastrointestinal, respiratory and reproductive systems all passed in the tests performed. The failure rate for antiprotozoals, antimalarials, antifungals, anthelminthics and analgesics was 14.3%, 12.5%, 11.8%, 8.9% and 11.5%, respectively.en_US
dc.language.isoenen_US
dc.publisherUniveristy of Nairobien_US
dc.titleQuality performance of drugs analyzed in the Drug Analysis and Research unit (DARU) during the period 2006-2010.en_US
dc.typeArticleen_US
dc.type.materialenen_US


Files in this item

Thumbnail
Name:
Abuga et al_Quality performance ...
Size:
29.78Kb
Format:
PDF
Description:
Abstract
View/Open

This item appears in the following Collection(s)

Show simple item record